Camp4 Therapeutics director Andrew J. Schwab disposes of 10 shares worth $45
CAMP•Director reports small share sale
- Camp4 Therapeutics director Andrew J. Schwab reported a sale of 10 common shares at USD 4.5 on Aug. 24, 2026.
- 5AM Ventures VI’s stake fell to 2,433,270 shares held indirectly following the transaction.
- Schwab also reported indirect holdings of 2,941,176 shares via 5AM Ventures VII and 302,770 shares via 5AM Opportunities II.
Related News
Freeport-McMoRan EVP, General Counsel Douglas N. Currault II disposes of common shares worth $6.28 million
FCX•
Karman Space & Defense Announces Planned CFO Transition
KRMN•
